Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline
ophthalmic solution compared to vehicle and its individual components in alleviating the
signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.